103 related articles for article (PubMed ID: 21471644)
21. Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
Castellano CA; Nugent S; Paquet N; Tremblay S; Bocti C; Lacombe G; Imbeault H; Turcotte É; Fulop T; Cunnane SC
J Alzheimers Dis; 2015; 43(4):1343-53. PubMed ID: 25147107
[TBL] [Abstract][Full Text] [Related]
22. Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer's type.
Gutierres JM; Carvalho FB; Schetinger MR; Marisco P; Agostinho P; Rodrigues M; Rubin MA; Schmatz R; da Silva CR; de P Cognato G; Farias JG; Signor C; Morsch VM; Mazzanti CM; Bogo M; Bonan CD; Spanevello R
Life Sci; 2014 Feb; 96(1-2):7-17. PubMed ID: 24291256
[TBL] [Abstract][Full Text] [Related]
23. Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers.
Schöll M; Almkvist O; Bogdanovic N; Wall A; Långström B; Viitanen M; Nordberg A
J Alzheimers Dis; 2011; 24(3):495-506. PubMed ID: 21297272
[TBL] [Abstract][Full Text] [Related]
24. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
25. Brain [18F]FDDNP binding and glucose metabolism in advanced elderly healthy subjects and Alzheimer's disease patients.
Tauber C; Beaufils E; Hommet C; Ribeiro MJ; Vercouillie J; Vierron E; Mondon K; Cottier JP; Gissot V; Guilloteau D; Camus V
J Alzheimers Dis; 2013; 36(2):311-20. PubMed ID: 23609763
[TBL] [Abstract][Full Text] [Related]
26. Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia.
Mosconi L; Andrews RD; Matthews DC
J Alzheimers Dis; 2013; 35(3):509-24. PubMed ID: 23478305
[TBL] [Abstract][Full Text] [Related]
27. Naringenin ameliorates Alzheimer's disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model.
Khan MB; Khan MM; Khan A; Ahmed ME; Ishrat T; Tabassum R; Vaibhav K; Ahmad A; Islam F
Neurochem Int; 2012 Dec; 61(7):1081-93. PubMed ID: 22898296
[TBL] [Abstract][Full Text] [Related]
28. Glucagon-like peptide-1 mediates effects of oral galactose in streptozotocin-induced rat model of sporadic Alzheimer's disease.
Knezovic A; Osmanovic Barilar J; Babic A; Bagaric R; Farkas V; Riederer P; Salkovic-Petrisic M
Neuropharmacology; 2018 Jun; 135():48-62. PubMed ID: 29501615
[TBL] [Abstract][Full Text] [Related]
29. Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?
Knezovic A; Loncar A; Homolak J; Smailovic U; Osmanovic Barilar J; Ganoci L; Bozina N; Riederer P; Salkovic-Petrisic M
J Neural Transm (Vienna); 2017 Jun; 124(6):695-708. PubMed ID: 28470423
[TBL] [Abstract][Full Text] [Related]
30. Assessment of mental deterioration with the Cognitive Abilities Screening Instrument (CASI) and glucose hypometabolism in Alzheimer's disease: the Osaki-Tajiri Project.
Yamaguchi S; Meguro K; Ishii H; Meguro M; Akanuma K
J Clin Neurosci; 2009 Nov; 16(11):1430-4. PubMed ID: 19632119
[TBL] [Abstract][Full Text] [Related]
31. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
Klupp E; Förster S; Grimmer T; Tahmasian M; Yakushev I; Sorg C; Yousefi BH; Drzezga A
Brain Connect; 2014 Jun; 4(5):371-83. PubMed ID: 24870443
[TBL] [Abstract][Full Text] [Related]
32. Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: a behavioral analysis.
Baluchnejadmojarad T; Roghani M
Pharmacology; 2006; 78(4):193-7. PubMed ID: 17065836
[TBL] [Abstract][Full Text] [Related]
33. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
34. ICV STZ induced impairment in memory and neuronal mitochondrial function: A protective role of nicotinic receptor.
Saxena G; Patro IK; Nath C
Behav Brain Res; 2011 Oct; 224(1):50-7. PubMed ID: 21620901
[TBL] [Abstract][Full Text] [Related]
35. A Pilot Study on Clinical and Neuroimaging Characteristics of Chinese Posterior Cortical Atrophy: Comparison with Typical Alzheimer's Disease.
Wang XD; Lu H; Shi Z; Cai L; Liu S; Liu S; Han T; Wang Y; Zhou Y; Wang X; Gao S; Ji Y
PLoS One; 2015; 10(8):e0134956. PubMed ID: 26267071
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
37. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
[TBL] [Abstract][Full Text] [Related]
38. Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.
Salkovic-Petrisic M; Knezovic A; Osmanovic-Barilar J; Smailovic U; Trkulja V; Riederer P; Amit T; Mandel S; Youdim MB
Life Sci; 2015 Sep; 136():108-19. PubMed ID: 26159898
[TBL] [Abstract][Full Text] [Related]
39. Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model.
Ponce-Lopez T; Liy-Salmeron G; Hong E; Meneses A
Brain Res; 2011 Dec; 1426():73-85. PubMed ID: 22036080
[TBL] [Abstract][Full Text] [Related]
40. Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay.
Förster S; Grimmer T; Miederer I; Henriksen G; Yousefi BH; Graner P; Wester HJ; Förstl H; Kurz A; Dickerson BC; Bartenstein P; Drzezga A
Biol Psychiatry; 2012 May; 71(9):792-7. PubMed ID: 21679929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
